Biotech News
-
Perimeter Medical Imaging AI Announces Important Milestone in ATLAS AI Project with Standalone AI Algorithm Achieving Key Performance Metrics
April 14, 2021 (Source) — ImgAssist AI Software Achieves 0.94 AUC After Utilizing Extensive Dataset of Images Collected…
-
Valeo Pharma Announces $4.0 Million Non-Brokered Private Placement of Non-Convertible Debentures
April 14, 2021 (Source) — Valeo insiders participate for $2.6 million Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE:…
-
Sixth Wave Demonstrates Colorimetric Detection of SARS-CoV-2 Utilizing AMIPs(TM)
April 14, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or…
-
Rritual Appoints Sarton Molnar-Fenton, Vice President Sales USA
April 13, 2021 (Source) — Senior Executive with vast CPG Experience to Lead Sales Function, Driving Growth for…
-
Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates
April 9, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Hemostemix Announces It Is Trading on the Frankfurt Stock Exchange and It Has Retained HE Capital Markets Ltd.
April 8, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0.F) (“Hemostemix” or the “Company”) is…
-
Physician-Led Webinar Sponsored by Perimeter Medical Imaging AI Highlights Advancements in Intraoperative Specimen Imaging
April 6, 2021 (Source) — Prestigious panel of physician experts provide commentary on Perimeter’s potentially transformative and disruptive…
-
DIAGNOS Enters into an Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
April 6, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a…
-
Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Redesca® and Redesca HP®
April 6, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”),…
-
StageZero Life Sciences Introduces Aristotle, The First Multi-Cancer Test From A Single Sample of Blood
April 5, 2021 (Source) — StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”) on Thursday April 1st, announced…
